164 related articles for article (PubMed ID: 16800389)
1. Human papillomavirus vaccines: challenges to implementation.
Garland SM
Sex Health; 2006 May; 3(2):63-5. PubMed ID: 16800389
[TBL] [Abstract][Full Text] [Related]
2. The impact of anti HPV vaccination on cervical cancer incidence and HPV induced cervical lesions: consequences for clinical management.
Brinkman JA; Caffrey AS; Muderspach LI; Roman LD; Kast WM
Eur J Gynaecol Oncol; 2005; 26(2):129-42. PubMed ID: 15857016
[TBL] [Abstract][Full Text] [Related]
3. [Human papillomavirus and cervical cancer: presence and future of vaccination].
Joura EA
Gynakol Geburtshilfliche Rundsch; 2004 Jun; 44(3):142-5. PubMed ID: 15211060
[TBL] [Abstract][Full Text] [Related]
4. Papillomavirus vaccines in clinical trials.
Galloway DA
Lancet Infect Dis; 2003 Aug; 3(8):469-75. PubMed ID: 12901889
[TBL] [Abstract][Full Text] [Related]
5. Human papillomavirus infection: an old disease, a new vaccine.
Giles M; Garland S
Aust N Z J Obstet Gynaecol; 2006 Jun; 46(3):180-5. PubMed ID: 16704468
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus vaccines and adolescents.
Kahn JA; Bernstein DI
Curr Opin Obstet Gynecol; 2005 Oct; 17(5):476-82. PubMed ID: 16141761
[TBL] [Abstract][Full Text] [Related]
7. The use of vaccines in the prevention and treatment of cervical cancer.
Davidson EJ; Kitchener HC; Stern PL
Clin Oncol (R Coll Radiol); 2002 Jun; 14(3):193-200. PubMed ID: 12109821
[TBL] [Abstract][Full Text] [Related]
8. Human papillomavirus vaccines in development: if they're successful in clinical trials, how will they be implemented?
Shaw AR
Gynecol Oncol; 2005 Dec; 99(3 Suppl 1):S246-8. PubMed ID: 16213009
[TBL] [Abstract][Full Text] [Related]
9. Strategies for the prevention of cervical cancer by human papillomavirus vaccination.
Williamson AL; Passmore JA; Rybicki EP
Best Pract Res Clin Obstet Gynaecol; 2005 Aug; 19(4):531-44. PubMed ID: 16150392
[TBL] [Abstract][Full Text] [Related]
10. Human papillomavirus vaccines for the prevention and treatment of cervical cancer.
Tomson TT; Roden RB; Wu TC
Curr Opin Investig Drugs; 2004 Dec; 5(12):1247-61. PubMed ID: 15648945
[TBL] [Abstract][Full Text] [Related]
11. Prophylactic HPV vaccines: reducing the burden of HPV-related diseases.
Villa LL
Vaccine; 2006 Mar; 24 Suppl 1():S23-8. PubMed ID: 16194583
[TBL] [Abstract][Full Text] [Related]
12. [Possibilities of vaccination against HPV infections in cervix carcinoma].
Gissmann L
Zentralbl Gynakol; 2001 May; 123(5):299-301. PubMed ID: 11449623
[TBL] [Abstract][Full Text] [Related]
13. [Cervical cancer prevention: the impact of HPV vaccination].
Monsonégo J
Gynecol Obstet Fertil; 2006 Mar; 34(3):189-201. PubMed ID: 16529969
[TBL] [Abstract][Full Text] [Related]
14. Human papillomavirus vaccines.
Stanley MA
Rev Med Virol; 2006; 16(3):139-49. PubMed ID: 16710836
[TBL] [Abstract][Full Text] [Related]
15. How will HPV vaccines affect cervical cancer?
Roden R; Wu TC
Nat Rev Cancer; 2006 Oct; 6(10):753-63. PubMed ID: 16990853
[TBL] [Abstract][Full Text] [Related]
16. Emerging human papillomavirus vaccines.
Christensen ND
Expert Opin Emerg Drugs; 2005 Feb; 10(1):5-19. PubMed ID: 15757400
[TBL] [Abstract][Full Text] [Related]
17. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
Hantz S; Alain S; Denis F
Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
[TBL] [Abstract][Full Text] [Related]
18. [A vaccine to control cervix carcinoma will soon be available].
Vetter C
MMW Fortschr Med; 2006 Apr; 148(16):14. PubMed ID: 16688942
[No Abstract] [Full Text] [Related]
19. Prevention strategies of cervical cancer in the HPV vaccine era.
Bosch X; Harper D
Gynecol Oncol; 2006 Oct; 103(1):21-4. PubMed ID: 16919714
[No Abstract] [Full Text] [Related]
20. A comprehensive natural history model of HPV infection and cervical cancer to estimate the clinical impact of a prophylactic HPV-16/18 vaccine.
Goldie SJ; Grima D; Kohli M; Wright TC; Weinstein M; Franco E
Int J Cancer; 2003 Oct; 106(6):896-904. PubMed ID: 12918067
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]